In this study, we revealed that P-cadherin was intensely and broadly expressed in ovarian cancer, especially in endometrioid and serous subtypes, and demonstrated preserved expression in disseminated lesions similar to that of primary foci, but not in metastatic lymph nodes. The gene discussed is CDH3; the disease is ovarian cancer.